Fetal Soft Markers in Obstetric Ultrasound

Journal of Obstetrics and Gynaecology Canada

Volumn 27, Issue 6, 2005, Pages 592-612

  Van den Hof, Michiel C ^a   Wilson, R Douglas ^b   Bly, Stephen ^c   Gagnon, Robert ^a   Lewthwaite, Ms Barbara ^a   Lim, Ken ^a   Morin, Lucie ^a   Salem, Shia ^a   Allen, Victoria ^a   Blight, Claire ^a   Davies, Gregory ^a   Desilets, Valerie ^a   Gagnon, Alain ^a   Reid, Gregory ^a   Summers, Anne ^a   Wyatt, Phil ^a   Young, David C ^a  

^a Health Canada Radiation Protection Bureau ^*  (Canada)

^b Faculty of Engineering   (Canada)

^c HEALTH CANADA   (Canada)

Author keywords

Aneuploidy; Fetus; Genetic; Prenatal screening; Soft marker; Trisomy; Ultrasound

Indexed keywords

ANEUPLOIDY; ARTICLE; BONE LENGTH; BRACHYCEPHALY; BRAIN VENTRICLE DILATATION; CHOROID PLEXUS; CHOROID PLEXUS CYST; CISTERNA MAGNA; CLINODACTYLY; CYST; CYSTIC FIBROSIS; DOWN SYNDROME; EAR; EAR LENGTH; ECHOGENIC BOWEL; ECHOGENIC INTRACARDIAC FOCUS; ENLARGED CISTERNA MAGNA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMUR; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS KARYOTYPING; GENETIC SCREENING; HUMAN; HUMERUS; ILIAC ANGLE; ILIAC BONE; MATERNAL AGE; NASAL BONE; NECK; PATIENT COUNSELING; PYELECTASIS; SANDAL GAP; SINGLE UMBILICAL ARTERY; SKINFOLD THICKNESS; THICKENED NUCHAL FOLD; TOE; CANADA; CHROMOSOME ABERRATION; ECHOGRAPHY; FEMALE; MULTIPLE MALFORMATION SYNDROME; NUCHAL TRANSLUCENCY MEASUREMENT; PRACTICE GUIDELINE; PREGNANCY; SECOND TRIMESTER PREGNANCY; STANDARD;

BIOLOGICAL MARKER;

ABNORMALITIES, MULTIPLE; BIOLOGICAL MARKERS; CANADA; CHROMOSOME ABERRATIONS; FEMALE; GENETIC SCREENING; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, SECOND; ULTRASONOGRAPHY, PRENATAL;

EID: 24644497691     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30720-4     Document Type: Article

References (19)

1. Periodic health examination, 1992 update: 2. Routine prenatal ultrasound screening. Canadian Task Force on the Periodic Health Examination. Can Med J 1992;147(5):627-633.
2. Guidelines for the performance of ultrasound examination in obstetrics and gynaecology. J Soc Obstet Gynaecol Can 1995, 17:263-266. Society of Obstetricians and Gynaecologists of Canada.
3. Obstetric/gynaecologic ultrasound [policy statement]. J Soc Obstet Gynaecol Can 1997, 65:871-872. Society of Obstetricians and Gynaecologists of Canada.
4. Saari-Kemppainen A, Karjalainen O, Ylostalo P, Heinonen OP Ultrasound screening and perinatal mortality: controlled trial on systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet 1990, 336(8712):387-391.
5. Leivo T, Tuominen R, Saari-Kemppainen A, Ylostalo P, Karjalainen O, Heinonen OP Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial. Ultrasound Obstet Gynecol 1996, 7(5):309-314.
6. Long G, Sprigg A A comparative study of routine versus selective fetal anomaly ultrasound scanning. J Med Screen 1998, 5(1):6-10.
7. Nicolaides KH, Snijders RJ, Gosden CM, Berry C, Campbell S Ultrasonographically detectable markers of fetal aneuploidy. Lancet 1992, 340:704-707.
8. Bromley B, Lieberman E, Shipp TD, Benacerraf BR The genetic sonogram: a method of risk assessment for Dawn syndrome in the second trimester. J Ultrasound Med 2002, 21(10):1087-1096.
9. Stene J, Stene E, Mikkelsoen M Risk for chromosome abnormality at amniocentesis following a child with a non-inberited chromosome aberration. Prenatal Diagn 1984, 4(special issue):81-95.
10. Warburton D Genetic Factors Influencing Aneuploidy Frequency. Aneuploidy: etiology and mechanisms 1985, 133-148. Plenum, New York. V.L. Dellarco, P.K. Voytek, A. Hollaender (Eds.).
11. Guidelines for health care providers involved in prenatal screening and diagnosis. SOGC Clinicat Practice Guidelines 1998, 75. Society of Obstetricians and Gynaecologists of Canada.
12. Dick PT Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Dawn syndrome. Canadian Task Force on the Periodic Health Examination. Can Med J 1996, 154(4):465-479.
13. Vintzileos A, Guzman ER, Smulian JC, Yeo L, Scorza WE, Knuppel RA Second-rtimester genetic sonography in patients with advanced maternal age and normal triple screen. Obstet Gynecol 2002, 99(6):993-995.
14. DeVore GR, Romero R Combined use of genetic sonography and maternal serum triple marker screening: an effective method for increasing the detection of trisomy 21 in women younger than 35 years. J Ultrasound Med 2001, 20(6):645-654.
15. Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF Combined second-trimester biochemical and ultrasound screening for Dawn syndrome. Obstet Gynecol 2002, 100(6):1168-1176.
16. Rabbins JC, Lezotre DC, Persutte WH, DeVore GR, Benacerraf BR, Nyberg DA, et al. An 8-center study to evaluate the utility of mid-term genetic sonograms among high-risk pregnancies. J Ultrasound Med 2003, 22(1):33-38.
17. Verdin SM, Economides DL The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry. Br J Obstet Gynaecol 1998, 105:63-67.
18. Drugan A, Reichler A, Bronstein M, Johnson MP, Sokol RJ, Evan MI Abnormal biochemical serum screening versus 2nd rtimester ultrasounddetected minor anomalies as predictors of aneuploidy in low-risk patients. Fetal Diagn Ther 1996, 11:301-305.
19. Woolf SR, Battista RN, Angerson GM, Logan W, Eel AG Canadian Task Force on the Periodic Health Exam 1994, Canadian Communication Group, Ottawa.